ERA - Leading European Nephrology

My ERA Join ERA

Home | Video pages | Webcast | GLP-1 receptor agonists in patients with CKD not on dialysis; beyond cardiorenal protection

GLP-1 receptor agonists in patients with CKD not on dialysis; beyond cardiorenal protection

Share

https://www.youtube.com/watch?v=2QtDnRAWHa0 copy

Other e-seminars from EuReCa-M & Diabesity

Thyroid Hormone in CKD patients with diabetes: what is known, what is new

Long-term cardiovascular complications following AKI

Menopause and renal disease

What does the Cardiovascular-Kidney-Metabolic (CKM) Syndrome mean for nephrologists?

SGLT2 inhibitors and haemoglobin increase: a possible explanation of the cardiovascular benefits?

The impact of novel anticancer therapies on blood pressure and kidney function in patients with CKD

The role of exercise in patients with renal disease and metabolic syndrome

Heart failure in patients with CKD: diagnosis and therapeutic approaches

Calcification propensity: from biomarker to treatment target?

Crosstalk between bone and the vasculature in diabetes and CKD

Assessment and management of hypertension in dialysis patients

Echocardiography or Cardiac Magnetic resonance Imaging (or both) for cardiac assessment in CKD patients?